Fingerprint
Dive into the research topics of 'Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically